Month: March 2023

Aribio_Logo

AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s Disease Phase 2 Study at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD™ 2023)

Kaneka

KANEKA: “Development of Polymer Synthesis Technology by Microorganisms using CO2 as Direct Raw Material” selected as a NEDO Green Innovation Fund Project”

TOKYO--(BUSINESS WIRE)--Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka; hereinafter "Kaneka"), Bacchus Bio innovation Co., Ltd (Headquarters: Kobe-city, Hyogo; President:...

BIO-key-International-Inc-1-3

Cybersecurity Solutions Provider BIO-key’s 2022 Revenues Increased 37% to $7.0M Reflecting Growing Base of Annual Recurring Revenue; Investor Call Today at 10am ET

Expects record quarterly revenue in Q1 2023 WALL, N.J., March 31, 2023 (GLOBE NEWSWIRE) -- BIO-key®International, Inc. (Nasdaq: BKYI), an innovative...